The Pulmonary Fibrosis Associated MUC5B Promoter Polymorphism Is Prognostic of the Overall Survival in Patients with Non–Small Cell Lung Cancer (NSCLC) Receiving Definitive Radiotherapy

Ju Yang, Ting Xu, Daniel R. Gomez, Melenda Jeter, Lawrence B. Levy, Yipeng Song, Stephen Hahn, Zhongxing Liao, Xianglin Yuan

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'The Pulmonary Fibrosis Associated MUC5B Promoter Polymorphism Is Prognostic of the Overall Survival in Patients with Non–Small Cell Lung Cancer (NSCLC) Receiving Definitive Radiotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences